FTV

Fortive Corp (FTV) - Q2 2025 10-Q Summary

Business Context and Reporting Period

This filing covers the quarterly period ended June 27, 2025. Fortive Corporation operates in three strategic segments: Intelligent Operating Solutions (IOS), Precision Technologies (PT), and Advanced Healthcare Solutions (AHS). A material event during this period was the completion of the Precision Technologies Separation on June 28, 2025, where the PT segment was distributed to shareholders as a new independent company, Ralliant Corporation. Beginning in Q3 2025, PT results will be reported as discontinued operations.

Key Financial Metrics

Note: Total Debt includes $1.15 billion in Ralliant debt incurred in preparation for the separation, which was consolidated in the balance sheet prior to the distribution date.

Material Changes vs. Prior Period

• Revenue Decline: Total sales decreased 2.2% in Q2 and 2.7% YTD. Core revenue (excluding acquisitions, divestitures, and currency) declined 2.5% in Q2 and 2.1% YTD, driven by volume declines of 5.4% (Q2) and 4.5% (YTD), partially offset by favorable pricing of 2.9% and 2.4% respectively.
• Margin Compression: Operating profit margin decreased 480 basis points to 14.6% in Q2 (from 19.4% in Q2 2024). This was primarily due to $41 million in separation-related costs, volume declines, higher compensation, and tariff impacts. YTD margin decreased 440 basis points to 15.2%.
• One-Time Items: Q2 2024 included a $25.6 million loss from the Invetech divestiture and a $63.1 million gain on the sale of property, neither of which occurred in Q2 2025.
• Balance Sheet Shift: Cash and equivalents increased significantly to $1.83 billion, largely due to the receipt of a $1.15 billion dividend from Ralliant prior to the separation. Total debt increased due to the consolidation of Ralliant's new term loans prior to the spin-off.

Guidance, Outlook, and Risks

• Separation Impact: The company incurred $41 million in separation-related costs in Q2 and $64 million YTD. Ralliant will be classified as a discontinued operation starting Q3 2025.
• Trade and Tariffs: Management notes ongoing uncertainty regarding U.S. tariffs and retaliatory measures from China and other nations. While some tariffs are paused until August 2025, the company is actively managing supply chain disruptions and cost increases.
• Legislative Changes: The company is assessing the impact of the "One Big Beautiful Bill Act" (OBBBA) enacted in July 2025, which includes changes to expensing rules and international tax frameworks.
• Capital Allocation: Fortive repurchased 1.9 million shares in Q2 ($136 million) and 4.4 million shares YTD ($345 million). A special purpose repurchase program of up to $550 million was authorized using proceeds from the Ralliant dividend.
• Risks: Key risks include potential indemnification liabilities to Ralliant, foreign currency volatility, and the impact of global economic conditions on industrial and healthcare spending.

Investor Verification Checklist

• Discontinued Operations: Verify how the Q3 2025 financials will present the PT segment as discontinued operations and the impact on future comparability.
• Debt Structure: Confirm the post-separation debt load for Fortive, excluding the $1.15 billion Ralliant debt that was consolidated only until the distribution date.
• Tariff Exposure: Review specific segment exposure to tariffs, particularly in the PT and IOS segments, and the effectiveness of pricing countermeasures.
• Core Revenue Trends: Monitor the "Core Revenue" metric to distinguish organic volume/price trends from the noise of the separation and currency fluctuations.
• Share Repurchases: Track the utilization of the $550 million special purpose repurchase program funded by the Ralliant dividend.